Darren Wilbraham - Concepedia

Author

Darren Wilbraham

IQVIA (United Kingdom)

Also Known As

D Wilbraham, D. L. Wilbraham, D. Wilbraham, Darren WILBRAHAM, Darren Wilbraham

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

IQVIA (United Kingdom)Guy's Hospital Eli Lilly (United States)GW Pharmaceuticals (United Kingdom)Eli Lilly (United Kingdom)

About

Darren Wilbraham is an author at IQVIA (United Kingdom) specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	914
2	Public Health	1	1	100
3	Social Sciences	1	1	23
4	Allergy	1	1	580
5	Allergy Medicine	1	1	580

Darren Wilbraham

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Effect of an interleukin-4 variant on late phase asthmatic response to allergen challenge in asthmatic patients: results of two phase 2a studies Sally E. Wenzel, Darren Wilbraham, Rick Fuller, The Lancet InflammationAsthmaAllergyAllergy MedicineImmunology	2007	580
Effects of Suvorexant, an Orexin Receptor Antagonist, on Sleep Parameters as Measured by Polysomnography in Healthy Men Hong Sun, William P. Kennedy, Darren Wilbraham, SLEEP	2013	158
A phase I study to assess the single and multiple dose pharmacokinetics of THC/CBD oromucosal spray Colin Stott, Linda R. White, Stephen Wright, European Journal of Clinical Pharmacology Cannabis UsePharmacological StudyMedicinePharmacotherapyThc/cbd Oromucosal Spray	2012	115
A Phase I, open-label, randomized, crossover study in three parallel groups to evaluate the effect of Rifampicin, Ketoconazole, and Omeprazole on the pharmacokinetics of THC/CBD oromucosal spray in healthy volunteers Colin Stott, Linda R. White, Stephen Wright, SpringerPlus	2013	111
Efficacy and safety of a patch vaccine containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase 3, randomised, double-blind, placebo-controlled field trial in travellers from Europe to Mexico and Guatemala R.H. Behrens, Jakob P. Cramer, Tomáš Jelı́nek, The Lancet Infectious Diseases VaccinationVaccine SafetyVaccine ResearchPatch VaccineEscherichia Coli	2013	100
A phase I study to assess the effect of food on the single dose bioavailability of the THC/CBD oromucosal spray Colin Stott, Linda R. White, Stephen Wright, European Journal of Clinical Pharmacology Cannabis UseNutritionDietary ExposureMedicineHerb-drug Interaction	2012	68
Effects of lasmiditan on simulated driving performance: Results of two randomized, blinded, crossover studies with placebo and active controls Eric Pearlman, Darren Wilbraham, Ellen B. Dennehy, Human Psychopharmacology Clinical and Experimental	2020	61
Double‐blind, randomized, placebo‐controlled study of safety, tolerability, pharmacokinetics and pharmacodynamics of <scp>TAK</scp>‐683, an investigational metastin analogue in healthy men Graham Scott, Irfan Ahmad, Katy Howard, British Journal of Clinical Pharmacology	2012	42
Cardiac effects of amiselimod compared with fingolimod and placebo: results of a randomised, parallel‐group, phase I study in healthy subjects Tomohiko Harada, Darren Wilbraham, Guillemette de La Borderie, British Journal of Clinical Pharmacology	2016	35
Abuse Potential of Lasmiditan: A Phase 1 Randomized, Placebo‐ and Alprazolam‐Controlled Crossover Study Darren Wilbraham, Paul H. Berg, Max Tsai, The Journal of Clinical Pharmacology	2019	29

Page 1